GENERICally Speaking Hatch Waxman Bulletin

The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the generics business.

Vol. 2, No. 2

Summer 2012

Relevant court decisions highlighted in this issue:

  • Caraco Pharm. Labs., Ltd. v. Novo Nordisk A/S (page 4)
  • Otsuka Pharm. Co. v. Sandoz, Inc. (page 6)
  • Bayer Shering Pharma AG v. Lupin, Ltd. (page 8)


Oren D. Langer


Managing Partner, New York Office
Member of Executive Board

Ryan M. Schultz


Pronouns: he/him

Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date

Vol. 2, No. 1

Spring 2012

Vol. 2, No. 3

Fall 2012

Vol. 2, No. 4

Winter 2012